Characterisation of a novel group B oncolytic adenovirus, ColoAd1
<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...
Автор: | |
---|---|
Інші автори: | |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
2011
|
Предмети: |